mmHg or greater to be an absolute contraindication to mitral valve replacement. The increased risk of operation in these patients can only be justified if the prognosis is thereby improved. We have, however, been unable to find any report which specifically outlines the natural history of extreme pulmonary hypertension caused by mitral valve disease and reports of mitral valve surgery on such patients do not indicate the expected course of the disease in a comparable group not having surgery. The objectives of this study have been to outline the natural history of extreme pulmonary hypertension secondary to mitral valve disease, to determine the risks of surgery in such patients, and to discover if there is a group of patients in whom the risks of operation are not justified.
valve replacement 56 per cent. The overall mortality was 31 per cent. The risks of operation were increased in those with a long history ofcardiac symptoms, those over So years of age, and in the presence of associated aortic valve disease. The mean survival for those patients not having operation was only 2 4 ± o05 years. The mean follow-up periodfor those surviving operation has been 5 8 + o 6 years, and symptomatic improvement has been good.
The operations of mitral valvotomy and mitral valve replacement have greatly improved the prognosis of patients with mitral valve disease. It is generally recognized that patients with severe pulmonary hypertension are less likely to survive such operations (Emanuel and Ross, I967) . Despite this, it has been suggested, because of the potential benefits, that patients in this situation should not be refused surgery (Hamer et al., I968) . Barclay et al. (1972) considered a systolic pulmonary artery pressure of IIO mmHg or greater to be an absolute contraindication to mitral valve replacement. The increased risk of operation in these patients can only be justified if the prognosis is thereby improved. We have, however, been unable to find any report which specifically outlines the natural history of extreme pulmonary hypertension caused by mitral valve disease and reports of mitral valve surgery on such patients do not indicate the expected course of the disease in a comparable group not having surgery. The objectives of this study have been to outline the natural history of extreme pulmonary hypertension secondary to mitral valve disease, to determine the risks of surgery in such patients, and to discover if there is a group of patients in whom the risks of operation are not justified.
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Patients and methods
Case records from the Cardio-Thoracic Unit of the Northem General Hospital, Sheffield have been examined for the years I96I to 1972. Data on 586 patients with a principal diagnosis of mitral valve disease, who had had cardiac catheterization, were studied. Fortyeight patients had extreme pulmonary hypertension defined arbitrarily as a resting pulmonary artery systolic pressure equal to, or greater than, 8o mmHg. Details of the following were noted: pulmonary artery pressure; wedged pulmonary artery pressure (indirect left atrial pressure); electrocardiographic evidence of atrial fibrillation and of left and/or right ventricular hypertrophy;
x-ray evidence of cardiomegaly, left atrial enlargement, and pulmonary hypertension; presence of mitral valve calcification; relevant medical history; and the nature of valve lesions. An estimate of pulmonary vascular resistance was made on the basis of Wood's findings (I954), who showed that it was linearly related to the pulmonary pressure gradient (mean pulmonary artery pressure -mean left atrial pressure); a pulmonary vascular resistance of 6 to IO It has been suggested that other factors increase the hazards of operation (Turner, I967) . In the present study, atrial fibrillation, mitral valve calcification, and a long history of symptoms were more common in those who died after operation than in those who survived. These patients were also older than the survivors. The situation is complicated by the frequent occurrence of these factors in combination in the same patient, making it difficult to assess the part played by any one of them in affecting the prognosis. Emanuel 
